Cargando…
Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. M...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667042/ https://www.ncbi.nlm.nih.gov/pubmed/36408182 http://dx.doi.org/10.3389/fonc.2022.1057631 |
_version_ | 1784831641457262592 |
---|---|
author | Rizzo, Stefania Raia, Giorgio Del Grande, Maria Gasparri, Maria Luisa Colombo, Ilaria Manganaro, Lucia Papadia, Andrea Del Grande, Filippo |
author_facet | Rizzo, Stefania Raia, Giorgio Del Grande, Maria Gasparri, Maria Luisa Colombo, Ilaria Manganaro, Lucia Papadia, Andrea Del Grande, Filippo |
author_sort | Rizzo, Stefania |
collection | PubMed |
description | OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. METHODS: This systematic review was conducted according to the PRISMA-DTA statement and the protocol was registered on Prospero. A comprehensive literature search of 3 electronic databases was performed by two authors. For each eligible article, information was collected concerning the clinical setting; basic study data; population characteristics; technical aspects; body composition features; chemotherapy drugs administered; association of body composition values and toxicities. The overall quality of the included studies was critically evaluated. RESULTS: After the initial retrieval of 812 articles, the systematic review included 6 articles (5/6 studies were retrospective; one was prospective). The number of patients ranged between 69 and 239; mean/median age ranged between 55 and 65 years; the percentage of sarcopenic patients ranged between 25% and 54%. The cut-off values to define sarcopenia and the vertebral levels for evaluation of body composition were different. Five studies included chemotherapy based on carboplatin and paclitaxel, 1 included chemotherapy based on pegylated liposomal doxorubicin. Among the studies including carboplatin and paclitaxel, 3/5 demonstrated an association with toxicity, whereas 2/5 did not. Altogether, 4/6 papers demonstrated an association between the body composition values and the development of chemotherapy-related toxicities. CONCLUSIONS: There is a wide variability of results about the association of body composition and chemotherapy-related toxicity in ovarian cancer patients. Therefore further studies, possibly including a comprehensive assessment of body compartments and where the definition of body composition cut-offs is constant, are warranted to better understand this association. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022337753, identifier (CRD42022337753). |
format | Online Article Text |
id | pubmed-9667042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96670422022-11-17 Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review Rizzo, Stefania Raia, Giorgio Del Grande, Maria Gasparri, Maria Luisa Colombo, Ilaria Manganaro, Lucia Papadia, Andrea Del Grande, Filippo Front Oncol Oncology OBJECTIVES: The main objective of this systematic review was to examine the literature evaluating association of image-based body composition with chemotherapy-related toxicity in ovarian cancer patients. A secondary objective was to evaluate the different definitions of sarcopenia across studies. METHODS: This systematic review was conducted according to the PRISMA-DTA statement and the protocol was registered on Prospero. A comprehensive literature search of 3 electronic databases was performed by two authors. For each eligible article, information was collected concerning the clinical setting; basic study data; population characteristics; technical aspects; body composition features; chemotherapy drugs administered; association of body composition values and toxicities. The overall quality of the included studies was critically evaluated. RESULTS: After the initial retrieval of 812 articles, the systematic review included 6 articles (5/6 studies were retrospective; one was prospective). The number of patients ranged between 69 and 239; mean/median age ranged between 55 and 65 years; the percentage of sarcopenic patients ranged between 25% and 54%. The cut-off values to define sarcopenia and the vertebral levels for evaluation of body composition were different. Five studies included chemotherapy based on carboplatin and paclitaxel, 1 included chemotherapy based on pegylated liposomal doxorubicin. Among the studies including carboplatin and paclitaxel, 3/5 demonstrated an association with toxicity, whereas 2/5 did not. Altogether, 4/6 papers demonstrated an association between the body composition values and the development of chemotherapy-related toxicities. CONCLUSIONS: There is a wide variability of results about the association of body composition and chemotherapy-related toxicity in ovarian cancer patients. Therefore further studies, possibly including a comprehensive assessment of body compartments and where the definition of body composition cut-offs is constant, are warranted to better understand this association. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022337753, identifier (CRD42022337753). Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9667042/ /pubmed/36408182 http://dx.doi.org/10.3389/fonc.2022.1057631 Text en Copyright © 2022 Rizzo, Raia, Del Grande, Gasparri, Colombo, Manganaro, Papadia and Del Grande https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Rizzo, Stefania Raia, Giorgio Del Grande, Maria Gasparri, Maria Luisa Colombo, Ilaria Manganaro, Lucia Papadia, Andrea Del Grande, Filippo Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title | Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title_full | Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title_fullStr | Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title_full_unstemmed | Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title_short | Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review |
title_sort | body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: a systematic review |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667042/ https://www.ncbi.nlm.nih.gov/pubmed/36408182 http://dx.doi.org/10.3389/fonc.2022.1057631 |
work_keys_str_mv | AT rizzostefania bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT raiagiorgio bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT delgrandemaria bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT gasparrimarialuisa bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT colomboilaria bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT manganarolucia bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT papadiaandrea bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview AT delgrandefilippo bodycompositionasapredictorofchemotherapyrelatedtoxicityinovariancancerpatientsasystematicreview |